MoU5 Jan 2026, 03:18 pm
Shukra Pharmaceuticals Ltd. Signs MoU with Borns Medical Robotics Inc., USA for Collaboration in Robotic Surgical Technologies
AI Summary
Shukra Pharmaceuticals Limited has entered into a Memorandum of Understanding (MoU) with Borns Medical Robotics Inc., USA, to introduce, promote, and commercialize next-generation Al-enabled soft-tissue surgical robotic systems across India and select South Asian markets. The collaboration aims to expand access to advanced robot-assisted minimally invasive soft-tissue surgeries, integrate AI and digital surgery workflows, and strengthen regional healthcare infrastructure. The strategic alliance aligns with Shukra Pharmaceuticals' long-term growth strategy and is expected to enhance its market positioning, create new revenue opportunities, and strengthen its brand visibility in the global surgical robotics market.
Key Highlights
- Shukra Pharmaceuticals Ltd. has signed an MoU with Borns Medical Robotics Inc., USA.
- The collaboration aims to introduce, promote, and commercialize next-generation Al-enabled soft-tissue surgical robotic systems in India and select South Asian markets.
- The partnership focuses on expanding access to advanced robot-assisted surgeries, integrating AI and digital surgery workflows, and strengthening regional healthcare infrastructure.
- The strategic alliance aligns with Shukra Pharmaceuticals' long-term growth strategy and is expected to enhance its market positioning, create new revenue opportunities, and strengthen its brand visibility in the global surgical robotics market.
- The MOU is non-binding in nature and outlines the intent of the parties to explore definitive agreements in due course, subject to detailed commercial terms, regulatory approvals, and mutual consent.